Leap Therapeutics Files 8-K on Financials and Operations

Ticker: CYPH · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1509745

Leap Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyLeap Therapeutics, INC. (CYPH)
Form Type8-K
Filed DateMar 26, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, operations, reporting

TL;DR

Leap Therapeutics dropped an 8-K on March 26th detailing their financial condition and operations.

AI Summary

On March 26, 2025, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with other events and financial statements. Leap Therapeutics, Inc. is incorporated in Delaware and is in the pharmaceutical preparations industry.

Why It Matters

This 8-K filing provides crucial updates on Leap Therapeutics' financial health and operational status, which are key indicators for investors and stakeholders.

Risk Assessment

Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any immediate or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Leap Therapeutics, Inc.?

The primary purpose of this 8-K filing is to report on Leap Therapeutics, Inc.'s results of operations and financial condition, as well as other events and financial statements.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on March 26, 2025.

In which state is Leap Therapeutics, Inc. incorporated?

Leap Therapeutics, Inc. is incorporated in Delaware.

What is the business address of Leap Therapeutics, Inc.?

The business address of Leap Therapeutics, Inc. is 47 Thorndike Street, Suite B1-1, Cambridge, MA 02141.

What is the Standard Industrial Classification (SIC) code for Leap Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Leap Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding LEAP THERAPEUTICS, INC. (CYPH).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing